Antani, Abraham B.

HRN: 21-93-42  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
09/21/2022
09/23/2022
PO
5ml
BID
Ascariasis
Waiting Final Action 
09/23/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/23/2022
09/30/2022
PO
4ml
Q8
T/C Amoebisis
Waiting Final Action 
09/24/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/24/2022
10/02/2022
IVTT
712mg
Q6
Sepsis
Waiting Final Action 
09/24/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/24/2022
09/30/2022
IV
150mg
Q8
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: